Repligen [RGEN] vs Baxter International [BAX] Detailed Stock Comparison

Repligen Corporation

NASDAQ
Loading...

Baxter International Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Repligen Corporation wins in 9 metrics, Baxter International Inc. wins in 11 metrics, with 0 ties. Baxter International Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Repligen Corporation Baxter International Inc. Better
P/E Ratio (TTM) 154.30 86.31 Baxter International Inc.
Price-to-Book Ratio 3.55 1.54 Baxter International Inc.
Debt-to-Equity Ratio 32.76 160.28 Repligen Corporation
PEG Ratio -1.10 0.73 Baxter International Inc.
EV/EBITDA 59.13 8.55 Baxter International Inc.
Profit Margin (TTM) 6.62% -8.51% Repligen Corporation
Operating Margin (TTM) 8.26% 7.36% Repligen Corporation
EBITDA Margin (TTM) 8.26% 7.36% Repligen Corporation
Return on Equity 2.40% -13.71% Repligen Corporation
Return on Assets (TTM) 0.99% 2.83% Baxter International Inc.
Free Cash Flow (TTM) $91.69M $323.00M Baxter International Inc.
Dividend Yield N/A 1.77% N/A
1-Year Return 2.41% -31.87% Repligen Corporation
Price-to-Sales Ratio (TTM) 10.14 0.85 Baxter International Inc.
Enterprise Value $7.36B $17.26B Baxter International Inc.
EV/Revenue Ratio 9.97 1.54 Baxter International Inc.
Gross Profit Margin (TTM) 52.46% 19.40% Repligen Corporation
Revenue per Share (TTM) $13 $22 Baxter International Inc.
Earnings per Share (Diluted) $0.86 $-1.75 Repligen Corporation
Beta (Stock Volatility) 1.19 0.62 Baxter International Inc.
Short % of Float 9.88% 12.33% Repligen Corporation

Repligen Corporation vs Baxter International Inc. Stock Performance Analysis

Loading Price Chart...

RGEN
BAX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Repligen Corporation0.21%4.42%27.22%13.69%-18.50%-20.37%
Baxter International Inc.-0.24%8.16%20.29%21.84%6.55%6.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Repligen Corporation2.41%-17.06%-33.82%517.16%3,568.26%4,563.93%
Baxter International Inc.-31.87%-54.01%-74.19%-53.06%-34.17%1.07%

Performance & Financial Health Analysis: Repligen Corporation vs Baxter International Inc.

MetricRGENBAX
Market Information
Market Cap i$7.49B$9.38B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i734,7416,387,585
90 Day Avg. Volume i871,3507,931,785
Last Close$130.87$20.81
52 Week Range$100.99 - $175.77$15.73 - $31.76
% from 52W High-25.54%-34.48%
All-Time High$327.32 (Sep 20, 2021)$95.19 (Apr 20, 2020)
% from All-Time High-60.02%-78.14%
Growth Metrics
Quarterly Revenue Growth0.18%0.08%
Quarterly Earnings Growth0.18%0.08%
Financial Health
Profit Margin (TTM) i0.07%-0.09%
Operating Margin (TTM) i0.08%0.07%
Return on Equity (TTM) i0.02%-0.14%
Debt to Equity (MRQ) i32.76160.28
Cash & Liquidity
Book Value per Share (MRQ)$37.39$11.92
Cash per Share (MRQ)$13.63$3.82
Operating Cash Flow (TTM) i$117.42M$845.00M
Levered Free Cash Flow (TTM) i$76.07M$2.43B
Dividends
Last 12-Month Dividend Yield iN/A1.77%
Last 12-Month Dividend iN/A$0.36

Valuation & Enterprise Metrics Analysis: Repligen Corporation vs Baxter International Inc.

MetricRGEN (Apr 21, 2026)BAX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i154.3086.31
Forward P/E i52.719.09
PEG Ratio i-1.100.73
Price to Sales (TTM) i10.140.85
Price to Book (MRQ) i3.551.54
Market Capitalization
Market Capitalization i$7.49B$9.38B
Enterprise Value i$7.36B$17.26B
Enterprise Value Metrics
Enterprise to Revenue i9.971.54
Enterprise to EBITDA i59.138.55
Risk & Other Metrics
Beta i1.190.62
Book Value per Share (MRQ) i$37.39$11.92

Financial Statements Comparison: Repligen Corporation vs Baxter International Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRGEN (2025)BAX (2025)
Revenue/Sales i738.26M11.24B
Cost of Goods Sold i352.01M7.87B
COGS % of Revenue i47.7%69.9%
Gross Profit i386.25M3.38B
Gross Margin i52.3%30.1%
Research & Development i54.18M518.00M
Operating Income (EBIT) i41.56M177.00M
Operating Margin i5.6%1.6%
EBITDA i139.67M1.26B
EBITDA Margin i18.9%11.2%
Pre-Tax Income i62.38M-505.00M
Pre-Tax Income % of Revenue i8.5%-4.5%
Income Tax i13.49M395.00M
Income Tax % of Revenue i1.8%3.5%
Net Income (Profit) i48.89M-957.00M
Profit Margin i6.6%-8.5%

Balance Sheet & Liquidity Metrics

MetricRGEN (2025)BAX (2025)
Cash & Equivalents i566.02M1.97B
Total Current Assets i1.14B6.87B
Total Current Assets % of Revenue i154.1%61.1%
Total Current Liabilities i135.83M2.97B
Total Current Liabilities % of Revenue i18.4%26.4%
Long-Term Debt i668.39M9.70B
Long-Term Debt % of Revenue i90.5%86.2%
Total Shareholders Equity i2.11B6.10B
Retained Earnings i456.25M13.71B
Retained Earnings % of Revenue i61.8%121.9%
Property, Plant & Equipment i267.49M651.00M

Cash Flow Statement Comparison

MetricRGEN (2025)BAX (2025)
Operating Cash Flow i113.36M-24.00M
Operating Cash Flow % of Revenue i15.4%-0.2%
Capital Expenditures i-23.28MN/A
Free Cash Flow i91.69M323.00M
FCF Margin i12.4%2.9%
Debt Repayment i0-5.79B
Common Stock Repurchase i0N/A

Short Interest & Institutional Ownership Analysis

MetricRGENBAX
Shares Short i5.56M40.31M
Short Ratio i6.384.11
Short % of Float i9.88%12.33%
Shares Outstanding i56.33M514.28M
Float Shares i53.30M512.05M
% Held by Insiders i5.29%0.32%
% Held by Institutions i112.70%109.89%
% Held by Public i-17.99%-10.21%

Dividend Analysis & Yield Comparison: Repligen Corporation vs Baxter International Inc.

MetricRGENBAX
Last 12-Month Dividend iN/A$0.36
Last 12-Month Dividend Yield iN/A1.77%
3-Year Avg Annual Dividend iN/A$0.81
3-Year Avg Dividend Yield iN/A0.57%
3-Year Total Dividends iN/A$2.44
Ex-Dividend DateN/AFeb 27, 2026